| 書目名稱 | Fibrinolytics and Antifibrinolytics |
| 編輯 | F. Markwardt |
| 視頻video | http://file.papertrans.cn/343/342522/342522.mp4 |
| 叢書名稱 | Handbook of Experimental Pharmacology |
| 圖書封面 |  |
| 描述 | Disturbances of haemostasis and thromboembolic disorders still constitute a great problem in clinical practice. Increasing insight into the mechanism of blood coagula- tion has led to more effective therapy and prophylaxis. Particularly, the understand- ing of the biochemistry of fibrinolysis has provided possibilities for the pharma- cological interference of these processes, which has resulted in effective haemostatic agents and useful antithrombotic ones. The development of antifibrinolytics for interfering with pathological fibrinolytic processes is nearly complete and has led to the development of drugs essential to the therapy of hyperfibrinolytic bleeding. The search for fibrinolytics for dissolving intravascular thrombi has led to highly effective compounds. This development is still under way and promising results are hoped. Spontaneous dissolution of blood clots is a phenomenon which was described a century ago. First investigations of this process assured that there is in the organism a system capable of removing the fibrin which is formed during blood coagulation after it has fulfilled its physiological function. This fibrinolytic system is specifically adapted to the d |
| 出版日期 | Book 1978 |
| 關(guān)鍵詞 | Antifibrinolytikum; Fibrinolytikum; biochemistry; chemistry; research; therapy |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-642-66863-0 |
| isbn_softcover | 978-3-642-66865-4 |
| isbn_ebook | 978-3-642-66863-0Series ISSN 0171-2004 Series E-ISSN 1865-0325 |
| issn_series | 0171-2004 |
| copyright | Springer-Verlag Berlin · Heidelberg 1978 |
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-7 01:54
發(fā)表于 2025-3-21 18:34:14
